Endocrinology
From the Journals
Nearly one in five U.S. adolescents have prediabetes
Prediabetes is more common in male adolescents than in female adolescents in the United States.
Conference Coverage
DAPA-HF: Dapagliflozin benefits regardless of age, HF severity
PHILADELPHIA – The SGLT2 inhibitor had similar efficacy in the elderly, and across the spectrum of baseline symptom status.
Conference Coverage
Elagolix is effective second-tier treatment for endometriosis-associated dysmenorrhea
PHILADELPHIA – It has a very low adverse event profile and is well tolerated.
Conference Coverage
Findings confirm link between methimazole and risk for acute pancreatitis
CHICAGO – However, there is no evidence of a cumulative dose effect.
Conference Coverage
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics
PHILADELPHIA –
News from the FDA/CDC
FDA panel supports Vascepa expanded indication for CVD reduction
Icosapent ethyl (Vascepa), purified eicosapentaenoic acid, got unanimous support from an FDA panel for a new indication of reducing CVD events.
Conference Coverage
New model for CKD risk draws on clinical, demographic factors
The equation has demonstrated high discrimination and variable calibration across a range of populations.
Latest News
Levothyroxine dose for checkpoint inhibitor toxicity may be too high
CHICAGO – Dosing need not be automatically boosted when starting checkpoint inhibitor therapy.
Latest News
T3 levels are higher in combatants with PTSD
CHICAGO – Chronic catecholamine elevation may have a role in the thyroid hormone abnormality.
Conference Coverage
Lifestyle program improves chance of spontaneous conception for women with obesity
PHILADELPHIA – Lifestyle interventions aimed at healthy eating and physical activity in women with obesity could...
Conference Coverage
Hormone therapy in transgender patients is safe for bone
ORLANDO – An analysis of the available literature on bone health in transwomen and transmen receiving hormone therapy showed that transwomen had...